View in EDS HTML Full Text PDF Full Text

Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.

Saved in:
Bibliographic Details
Title: Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
Authors: Sahu S; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Sullivan TL; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Mitrophanov AY; Statistical Consulting and Scientific Programming, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland, United States of America., Galloux M; Independent bioinformatician, Marseille, France., Nousome D; CCR Bioinformatics Resource, Leidos Biomedical Sciences, Inc. Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Southon E; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Caylor D; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Mishra AP; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Evans CN; Genome Modification Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Clapp ME; Genome Modification Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Burkett S; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Malys T; Statistical Consulting and Scientific Programming, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland, United States of America., Chari R; Genome Modification Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Biswas K; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Sharan SK; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.
Source: PLoS genetics [PLoS Genet] 2023 Sep 15; Vol. 19 (9), pp. e1010940. Date of Electronic Publication: 2023 Sep 15 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101239074 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7404 (Electronic) Linking ISSN: 15537390 NLM ISO Abbreviation: PLoS Genet Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37713444
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sahu+S%22">Sahu S</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Sullivan+TL%22">Sullivan TL</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Mitrophanov+AY%22">Mitrophanov AY</searchLink>; Statistical Consulting and Scientific Programming, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Galloux+M%22">Galloux M</searchLink>; Independent bioinformatician, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Nousome+D%22">Nousome D</searchLink>; CCR Bioinformatics Resource, Leidos Biomedical Sciences, Inc. Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Southon+E%22">Southon E</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Caylor+D%22">Caylor D</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Mishra+AP%22">Mishra AP</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Evans+CN%22">Evans CN</searchLink>; Genome Modification Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Clapp+ME%22">Clapp ME</searchLink>; Genome Modification Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Burkett+S%22">Burkett S</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Malys+T%22">Malys T</searchLink>; Statistical Consulting and Scientific Programming, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Chari+R%22">Chari R</searchLink>; Genome Modification Core, Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Biswas+K%22">Biswas K</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Sharan+SK%22">Sharan SK</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101239074%22">PLoS genetics</searchLink> [PLoS Genet] 2023 Sep 15; Vol. 19 (9), pp. e1010940. <i>Date of Electronic Publication: </i>2023 Sep 15 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101239074 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7404 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537390%22">15537390 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Genet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37713444
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pgen.1010940
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1010940
    Titles:
      – TitleFull: Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sahu S
      – PersonEntity:
          Name:
            NameFull: Sullivan TL
      – PersonEntity:
          Name:
            NameFull: Mitrophanov AY
      – PersonEntity:
          Name:
            NameFull: Galloux M
      – PersonEntity:
          Name:
            NameFull: Nousome D
      – PersonEntity:
          Name:
            NameFull: Southon E
      – PersonEntity:
          Name:
            NameFull: Caylor D
      – PersonEntity:
          Name:
            NameFull: Mishra AP
      – PersonEntity:
          Name:
            NameFull: Evans CN
      – PersonEntity:
          Name:
            NameFull: Clapp ME
      – PersonEntity:
          Name:
            NameFull: Burkett S
      – PersonEntity:
          Name:
            NameFull: Malys T
      – PersonEntity:
          Name:
            NameFull: Chari R
      – PersonEntity:
          Name:
            NameFull: Biswas K
      – PersonEntity:
          Name:
            NameFull: Sharan SK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 09
              Text: 2023 Sep 15
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1553-7404
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: PLoS genetics
              Type: main
ResultId 1